[Atypical antipsychotic induced weight gain and metabolic disorders].

  title={[Atypical antipsychotic induced weight gain and metabolic disorders].},
  author={G PaulaRojas and A CatalinaPoblete and G XimenaOrellana and A KarenRouliez and G ClaudioLiberman},
  journal={Revista medica de Chile},
  volume={137 1},
The advent of new antipsychotic drugs has improved the treatment of schizophrenic patients as well as those suffering from other severe psychiatric disorders. Its widespread use, however, has been associated to the development of obesity and metabolic disturbances such as diabetes mellitus, dyslipidemia and increased coronary risk. This has caused a serious concern, due to the high cardiovascular mortality that prematurely affects these patients. The etiology of these abnormalities is still a… CONTINUE READING